Diabetes | CHOP Research Institute
 

Diabetes

Utilizing the Bionic Pancreas in Cystic Fibrosis Related Diabetes

Insulin therapy, commonly given as multiple daily injection therapy, is the only recommended treatment for Cystic Fibrosis Related Diabetes (CFRD).

DISCOVERY Study

The DISCOVERY Study is a new, national effort to learn about the causes of type 2 diabetes in children.

FrexalimAB in preservation of endogenous insULIN secretion compared to placebo in adUlts and adolescents on top of inSulin therapy (FABULINUS)

FrexalimAB in preservation of endogenous insULIN secretion compared to placebo in adUlts and adolescents on top of inSulin therapy (FABULINUS)

The goal of this Phase 2 study is to assess safety and efficacy of frexalimab to preserve β-cell function in participants with newly diagnosed type 1 diabetes (T1D).

Skeletal Health and Diseases Research Affinity Group

Skeletal Health and Diseases RAG

Promoting and fostering new research ventures and collaborations among our community of basic and translational investigators, clinician-scientists, and clinicians with shared interests in skeletal health and diseases

PETITE-T1D

PETITE-T1D

The purpose of this study is to evaluate the safety and pharmacokinetics (drug levels in the blood) of teplizumab in children less than 8 years old.

Designate - Siplizumab in T1DM

Designate - Siplizumab in T1DM

The goal of this study is to identify a safe dosing regimen for siplizumab in participants with type 1 diabetes.

Cornerstone Blog

Reaching New Heights With Crossword Puzzles and Radio-controlled Planes

Published on
Jul 29, 2022
Reaching New Heights With Crossword Puzzles, Radio-controlled Planes
Dr. Levine’s great pastimes outside of his endocrinology lab are crossword puzzles and flying radio-controlled airplanes with his grandsons.
Cornerstone Blog

Celebrate Diversity Month: Q&A With Featured Research Trainee, Anna Ada Dattoli, PhD

Published on
Apr 28, 2022
Celebrate Diversity Month: Q&A With Trainee Anna Ada Dattoli, PhD
Our Featured Trainee for April, Anna Ada Dattoli, PhD, discusses Celebrate Diversity Month and her research on diabetes.
Jacquelyn Anne Hatch-Stein, MD
Jacquelyn Anne Hatch-Stein

Dr. Hatch-Stein's research interests include diabetes, thyroid disorders, and disorders of growth and puberty. Recent clinical research projects include "Bone Health and Cardiovascular Risk in Turner Syndrome" and "Patterns of Height Velocity in Down Syndrome."

E-mail:
hatchsteinj [at] chop.edu

Teplizumab in New-Onset Type 1 Diabetes

Teplizumab in New-Onset Type 1 DiabetesTeplizumab in New-Onset Type 1 Diabetes

This is a study that investigates whether an IV medication (teplizumab) will slow or halt the progression of type 1 diabetes in children and adolescents (ages 8 - 17 years).